Home/ Stocks/ ORGO

Organogenesis Holdings Inc. Class A Common Stock

ORGO XNAS

$1.86 -0.58 (-24.01%) ▼ 15-min delayed

Open

$1.75

High

$1.88

Low

$1.54

Volume

4.85M

Market Cap

$310.11M

About Organogenesis Holdings Inc. Class A Common Stock

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 854 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$37.23M	$-53,156,000	$-0.44
FY 2025	$564.17M	$37.03M	$0.16
Q3 2025	$150.86M	$21.57M	$0.11
Q2 2025	$101.00M	$-9,392,000	$-0.10

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for ORGO yet. Check out our latest market news or earnings calendar.

Get ORGO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Organogenesis Holdings Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.